Categorie > Liver Disease / Hepatitis

Novel Criteria To Differentiate Fibrosis From Steatohepatitis

Categorie : Liver Disease / Hepatitis
Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world. Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients. However, it is an invasive procedure, with rare but potentially life-threatening compl ...

read more Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world. Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients. However, it is an invasive procedure, with rare but potentially life-threatening compl read more Sun Mar 2010

Groundbreaking Research To Find Vaccine For Hepatitis C

Categorie : Liver Disease / Hepatitis
Researchers at the South West Liver Unit, based at Plymouth Hospitals NHS Trust and supported by the Peninsula Medical School, are working to save more lives and improve the health of Hepatitis C sufferers around the world by developing a vaccine for the disease... ...

read more Researchers at the South West Liver Unit, based at Plymouth Hospitals NHS Trust and supported by the Peninsula Medical School, are working to save more lives and improve the health of Hepatitis C sufferers around the world by developing a vaccine for the disease... read more Sun Mar 2010

Post-Op Liver Cancer Complications More Frequent At Low-Volume Hospitals

Categorie : Liver Disease / Hepatitis
The frequency of post-operative complications following surgery for liver cancer is associated with a hospital having a low volume of liver surgery. Investigators at The Cancer Institute of New Jersey (CINJ) are presenting that finding at the 63rd Annual Society of Surgical Oncology Symposium taking ...

read more The frequency of post-operative complications following surgery for liver cancer is associated with a hospital having a low volume of liver surgery. Investigators at The Cancer Institute of New Jersey (CINJ) are presenting that finding at the 63rd Annual Society of Surgical Oncology Symposium taking read more Sun Mar 2010

Joint Role Of Obesity And Alcohol In Increasing The Risk Of Liver Disease

Categorie : Liver Disease / Hepatitis
Obesity and alcohol act together to increase the risk of liver disease in both men and women according to two studies published on bmj.com today. These findings have significant clinical and public health implications. In the UK, rates of liver disease and obesity are increasing. Alcohol is a majo ...

read more Obesity and alcohol act together to increase the risk of liver disease in both men and women according to two studies published on bmj.com today. These findings have significant clinical and public health implications. In the UK, rates of liver disease and obesity are increasing. Alcohol is a majo read more Sun Mar 2010

The Liver: Multitasker, Regenerator And Vital For Health

Categorie : Liver Disease / Hepatitis
The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental -- there are no love songs about a broken liver -- it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems... ...

read more The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental -- there are no love songs about a broken liver -- it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems... read more Fri Mar 2010

New Screening System For Hepatitis C

Categorie : Liver Disease / Hepatitis
A newly designed system of identifying molecules for treating hepatitis C should enable scientists to discover novel and effective therapies for the dangerous and difficult-to-cure disease of the liver, says Zhilei Chen, a Texas A&M University assistant professor of chemical engineering who helped d ...

read more A newly designed system of identifying molecules for treating hepatitis C should enable scientists to discover novel and effective therapies for the dangerous and difficult-to-cure disease of the liver, says Zhilei Chen, a Texas A&M University assistant professor of chemical engineering who helped d read more Fri Mar 2010

Pharmasset Announces Complete Enrollment Of RG7128 Phase 2b Clinical Study

Categorie : Liver Disease / Hepatitis
Pharmasset, Inc. (Nasdaq: VRUS) announced the complete enrollment by Roche of the 12 week RG7128 Phase 2b study (PROPEL) of approximately 400 treatment-naive patients with hepatitis C virus (HCV) genotypes 1 and 4. The study remains blinded to Roche and Pharmasset... ...

read more Pharmasset, Inc. (Nasdaq: VRUS) announced the complete enrollment by Roche of the 12 week RG7128 Phase 2b study (PROPEL) of approximately 400 treatment-naive patients with hepatitis C virus (HCV) genotypes 1 and 4. The study remains blinded to Roche and Pharmasset... read more Fri Mar 2010

Dynavax Receives Canadian Approval To Conduct Phase 3 Trials Of HEPLISAVTM

Categorie : Liver Disease / Hepatitis
Dynavax Technologies Corporation (NASDAQ: DVAX) announced that Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration, has approved the initiation of the Company's next Phase 3 trials in Canada. Initiation of the Canadian studies is expected to facilitate enrollment for the ...

read more Dynavax Technologies Corporation (NASDAQ: DVAX) announced that Health Canada, the Canadian equivalent of the U.S. Food and Drug Administration, has approved the initiation of the Company's next Phase 3 trials in Canada. Initiation of the Canadian studies is expected to facilitate enrollment for the read more Fri Mar 2010

Novartis Gains Exclusive Rights To Debio 025, An Antiviral Agent In Phase IIb Development As Potential First-in-class Hepatitis C Therapy

Categorie : Liver Disease / Hepatitis
Novartis has gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of drugs called cyclophilin inhibitors which could become part of ...

read more Novartis has gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent currently in Phase IIb development for the treatment of hepatitis C. Debio 025 is the first in a new class of drugs called cyclophilin inhibitors which could become part of read more Fri Mar 2010

NovaShunt Starts Its Pivotal Clinical Study "PIONEER" To Demonstrate The Clinical Value Of The AFS System

Categorie : Liver Disease / Hepatitis
NovaShunt announced the initiation of its pivotal multi- center clinical study named PIONEER, a Prospective, multi-center, open label, non-randomized study to Investigate the safety and performance of the Automated Fluid Shunt in patients with ascites and diuretic Resistance... ...

read more NovaShunt announced the initiation of its pivotal multi- center clinical study named PIONEER, a Prospective, multi-center, open label, non-randomized study to Investigate the safety and performance of the Automated Fluid Shunt in patients with ascites and diuretic Resistance... read more Fri Mar 2010

Mayo Clinic Health Letter: Highlights From The February Issue

Categorie : Liver Disease / Hepatitis
Here are highlights from the February issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit ht ...

read more Here are highlights from the February issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit ht read more Fri Mar 2010

Enzyme Deficiency Protects Hepatitis C Patients From Treatment-Related Anemia

Categorie : Liver Disease / Hepatitis
Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether... ...

read more Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether... read more Fri Mar 2010

Ocera Therapeutics Completes Phase 2B Enrollment In The ASTUTE Trial

Categorie : Liver Disease / Hepatitis
Ocera Therapeutics, Inc. announced that the ASTUTE Study (AST-120 Used to Treat Hepatic Encephalopathy) has completed enrollment for its Phase 2B study ahead of schedule, with data expected mid 2010... ...

read more Ocera Therapeutics, Inc. announced that the ASTUTE Study (AST-120 Used to Treat Hepatic Encephalopathy) has completed enrollment for its Phase 2B study ahead of schedule, with data expected mid 2010... read more Fri Mar 2010

A New Model For The Treatment Of Liver Disease: A Mouse With A Human Liver

Categorie : Liver Disease / Hepatitis
How do you study - and try to cure in the laboratory - an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver... ...

read more How do you study - and try to cure in the laboratory - an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver... read more Fri Mar 2010

The Mouse With A Human Liver: A New Model For The Treatment Of Liver Disease

Categorie : Liver Disease / Hepatitis
How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver... ...

read more How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver... read more Fri Mar 2010

Histostem Participates In Clinical Trials Demonstrating The Effective Use Of Its Proprietary Stem Cells In The Treatment Of Cirrhosis Of The Liver

Categorie : Liver Disease / Hepatitis
AmStem Corporation (OTCBB: SCII) announced that Histostem Ltd. of South Korea ("Histostem"), has participated in a successful preclinical study of the use of its proprietary Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells (HMSCs) in the treatment of cirrhosis of the liver... ...

read more AmStem Corporation (OTCBB: SCII) announced that Histostem Ltd. of South Korea ( read more Fri Mar 2010

What Is Alcoholic Liver Disease? What Is Alcoholic Hepatitis?

Categorie : Liver Disease / Hepatitis
Alcoholic liver disease, also called alcoholic hepatitis, refers to a range of conditions and related symptoms that develop when the liver becomes damaged due to excessive intake of alcohol. While distinct from cirrhosis, alcoholic hepatitis is regarded as the earliest stage of alcoholic liver disea ...

read more Alcoholic liver disease, also called alcoholic hepatitis, refers to a range of conditions and related symptoms that develop when the liver becomes damaged due to excessive intake of alcohol. While distinct from cirrhosis, alcoholic hepatitis is regarded as the earliest stage of alcoholic liver disea read more Fri Mar 2010

More Reliable Biomarkers Needed For Liver Cancer Detection

Categorie : Liver Disease / Hepatitis
Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology. Two biomarkers used to complement ultrasound in the early detection of hepatocellular carci ...

read more Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology. Two biomarkers used to complement ultrasound in the early detection of hepatocellular carci read more Fri Mar 2010

Hepatitis B And C Remain Public Health Issue--Up To 5.3 Million Americans Infected

Categorie : Liver Disease / Hepatitis
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases ...

read more A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases read more Fri Mar 2010

Targeted Delivery Of Losartan Reduces Liver Inflammation And Scarring

Categorie : Liver Disease / Hepatitis
A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity... ...

read more A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity... read more Fri Mar 2010

1 | 2 | 3 | 4 next >>>

eHealth Guide News Abortion ADHD Aid / Disasters Alcohol / Addiction Allergy Alzheimer's Anxiety Arthritis Asthma / Respiratory Autism Bio-terrorism / Terrorism Biology / Biochemistry Bipolar Bird Flu / Avian Flu Blood / Hematology Body Aches Bones / Orthopaedics Breast Cancer Cancer / Oncology Cardiovascular / Cardiology Caregivers / Homecare Cholesterol CJD / vCJD / Mad Cow Disease Cleft Palate Clinical Trials / Drug Trials Colorectal Cancer Complementary Medicine / Alternative Medicine Compliance Conferences Cosmetic Medicine / Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction / Premature Ejaculation Eye Health / Optometry Fertility Flu / SARS GastroIntestinal Genetics Gout Headache / Migraine Health Insurance / Medical Insurance Hearing / Deafness HIV / AIDS Huntingtons Disease Hypertension Immune System / Vaccines Infectious Diseases / Bacteria / Viruses Irritable-Bowel Syndrome Liver Disease / Hepatitis Lung Cancer Lupus Lymphoma / Leukemia Medical Devices Medical Malpractice / Litigation Medical Students Medicare / Medicaid / Tricare Men's health Mental Health MRI / PET / Ultrasound MRSA / Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology / Neuroscience Nursing Nutrition/Agriculture Obesity / Weight Loss / Fitness Pain / Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Primary Care / General Practice Prostate Psychology / Psychiatry Public Health Radiology / Nuclear Medicine Rehabilitation Schizophrenia Seniors / Aging Sexual Health / STDs Sleep / Sleep Disorders Smoking / Quit Smoking Sports Medicine / Fitness Statins Stem Cell Research Stroke / Neuroprotection Transplants / Organ Donations Tropical Diseases Urology / Nephrology Veterinary Water Quality / Air Quality Women's Health / OBGYN Health Policy Health Jobs Listing